were used as blank controls (BC).
We cultured AT2 cells with an air-liquid culture system to maintain their phenotype and transduced them with adenoviruses for 5 days. F-1 shRNA (A) almost completely silenced flotillin-1 expression ( Figure 1A ). There was also a decrease in flotillin-2 expression although a significant amount of flotillin-2 remained in the F-1 shRNA (A)-treated AT2 cells ( Figure 1B ). Among F-2 shRNAs, F-2 shRNA (C) was the most effective in silencing flotillin-2 expression. This shRNA also reduced flotillin-1 expression ( Figure  1A and 1B), probably because the stability of flotillin-1 is dependent on flotillin-2 [8] . Using F-1 shRNA (A) and F-2 shRNA (C), we determined the effect of flotillin-1 and -2 silencing on surfactant secretion. There were no statistically significant differences in the basal and stimulated secretions between control and F-1 shRNA (A) -treated cells ( Figure  1C ). However, F-2 shRNA (C) reduced stimulated surfactant secretion. The basal secretion appears to be decreased in the F-2 shRNA (C)-treated cells but the difference did not reach a significant level. The control virus had no effect on surfactant secretion.
We next examined whether the loss of flotillin affects lipid raft formation. Because large amounts of cells were needed for this experiment, we used L2 cells, a rat lung epithelial cell line that expresses flotillin-1 and -2 [4] . We transduced L2 cells with F-1 shRNA (A) or F-2 shRNA (C). Infection efficiencies increased with the multiplicity of infection (MOI) of the virus as revealed by EGFP fluorescence (Supplementary information, Figure S1A ). Western blot analysis indicated a significant decrease in protein expression of flotillin-1 or -2 in a dose-dependent manner (Supplementary information, Figure S1B ). When compared with blank and virus controls, there were no obvious differences in the amounts of protein and cholesterol of the raft fractions between control and flotillin-1 or -2 knockdown cells (Supplementary information, Figure S1C and S1D). When cholesterol concentration was expressed as µg per µg protein, cholesterol content in the lipid raft fraction was enriched 3-, 10-, and 20-fold in comparison with non-raft fractions 3, 4, and 5. SNARE proteins were enriched in lipid rafts of AT2 cells [4] . We examined whether knockdown of flotillin leads to dissociation of SNAREs with lipid rafts. Following silencing, little flotillin-1 and -2 proteins were detected in any of the fractions, indicating an effective silencing. When raft fractions were probed for two plasma membrane SNARE proteins, syntaxin-2 and SNAP-23 [2] following silencing, there was no change in the association of these proteins with lipid rafts (Supplementary information, Figure S1E and S1F).
Lipid rafts are also reported to be involved in cholesterol homeostasis. We further investigated the effects of flotillin-1 and -2 silencing on cholesterol levels in L2 cells. Following silencing of flotillin-1 and -2, cell lysates were analyzed for total cholesterol levels. Our results indicated www.cell-research.com | Cell Research Narendranath Reddy Chintagari et al. 703 npg that there were no statistical significant differences in cholesterol levels under silencing conditions when compared with controls (Supplementary information, Figure S1G ). We conclude that flotillin-2 is required for surfactant secretion but not via influencing the association of SNAREs with the rafts or cholesterol homeostasis. The mechanisms by which flotillin-2 regulates surfactant secretion remain to be determined, but could be due to its effects on signaling pathways or cytosketetal rearrangement because flotillin-2 knockdown blocks the G-protein coupled receptor (GPCR)-mediated activation of p38 MAPK [9] and trans-negative mutant flotillin-2 leads to faulty localization of Vav, resulting in altered cytoskeletal rearrangements [10] .
